ACOG Guidelines

  • Committee Opinion 724, Consumer Testing for Disease Risk
  • Practice Bulletin 149, Endometrial Cancer
  • Committee Opinion 478, Family History as a Risk Assessment Tool
  • Technology Assessment 14, Modern Genetics in Obstetrics and Gynecology
  • Practice Bulletin 182, Hereditary Breast and Ovarian Cancer Syndrome
  • Committee Opinion 634, Hereditary Cancer Syndromes and Risk Assessment
  • Practice Bulletin 147, Lynch Syndrome
  • Genetics Toolkit – The Society of Gynecologic Oncology (SGO), the American College of Obstetricians and Gynecologists (ACOG), National Society of Genetic Counselors, Bright Pink, and Facing Our Risk of Cancer Empowered (FORCE) collaboratively developed this web-based resource addressing common issues surrounding hereditary risk assessment and genetic testing in women with, or worried about, gynecologic cancers. The toolkit includes a series of vignettes designed to help providers and patients understand the implications of a genetic test result.

Patient Education

Additional Resources

  • BRCA1 and BRCA2: Cancer Risk and Genetic Testing – This resource by the National Institutes of Health (NIH) National Cancer Institute provides information on BRCA1 and BRCA2 gene mutations.
  • Genetics and Cancer – This resource by the American Cancer Society focuses on the links between genes and cancer.
  • Genetics eModule – Developed by the American Society for Reproductive Medicine in collaboration with ACOG, this eModule covers a variety of genetics topics and allows participants to earn up to 7 AMA PRA Category 1 Credits™.
  • KNOW: BRCA Tool – This online tool developed by the Centers for Disease Control and Prevention (CDC) helps women understand their risks for having a BRCA1 or BRCA2 gene mutation.
  • Norton & Elaine Sarnoff Center for Jewish Genetics – This website provides an overview of the genetics behind carrier screening and hereditary cancer and information on the increased risk of certain genetic conditions in the Jewish population.
  • Ordering of Genetic Tests – This position statement, published by ACOG in November 2015, addresses providers’ ability to order genetic tests.